Answer
The selected UK product is licensed to reduce recurrence, not as an acute rescue treatment. New confusion or reduced alertness requires urgent clinical assessment.
Sources for this answer
- Rifaximin 550 mg film-coated tabletsemc · SmPC Current selected SmPC · Version 9
- NHSNHS · NHS medicine guidance